| 000 | 01899 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513160948.0 | ||
| 264 | 0 | _c19990401 | |
| 008 | 199904s 0 0 eng d | ||
| 022 | _a0732-8893 | ||
| 024 | 7 |
_a10.1016/s0732-8893(98)00118-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTabe, Y | |
| 245 | 0 | 0 |
_aMolecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates. _h[electronic resource] |
| 260 |
_bDiagnostic microbiology and infectious disease _cNov 1998 |
||
| 300 |
_a177-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmpicillin _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aCefazolin _xpharmacology |
| 650 | 0 | 4 |
_aCefmetazole _xpharmacology |
| 650 | 0 | 4 |
_aCross Infection _xepidemiology |
| 650 | 0 | 4 | _aDNA Restriction Enzymes |
| 650 | 0 | 4 |
_aDrug Resistance, Microbial _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xgenetics |
| 650 | 0 | 4 | _aElectrophoresis, Gel, Pulsed-Field |
| 650 | 0 | 4 |
_aGentamicins _xpharmacology |
| 650 | 0 | 4 | _aHospital Bed Capacity, 500 and over |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImipenem _xpharmacology |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aNeonatal Nursing |
| 650 | 0 | 4 | _aNursing Staff, Hospital |
| 650 | 0 | 4 |
_aOfloxacin _xpharmacology |
| 650 | 0 | 4 |
_aOxacillin _xpharmacology |
| 650 | 0 | 4 | _aPhylogeny |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xepidemiology |
| 650 | 0 | 4 |
_aStaphylococcus _xclassification |
| 650 | 0 | 4 |
_aTobramycin _xpharmacology |
| 650 | 0 | 4 |
_aVancomycin _xpharmacology |
| 700 | 1 | _aNakamura, A | |
| 700 | 1 | _aOguri, T | |
| 700 | 1 | _aIgari, J | |
| 773 | 0 |
_tDiagnostic microbiology and infectious disease _gvol. 32 _gno. 3 _gp. 177-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0732-8893(98)00118-7 _zAvailable from publisher's website |
| 999 |
_c9846664 _d9846664 |
||